National Institutes of Health (NIH) staff are getting ready to attend the Alzheimer’s Association International Conference (AAIC) 2017 in London, where dementia researchers, clinicians, advocates, and health care providers from around the world will meet on July 16–20. Some 4,000 members of the Alzheimer’s community are expected to attend, reporting on new findings and discussing the latest in emerging technologies and approaches to discovery. Our NIH contingent hopes to connect with you there!
A significant amount of discussion and presentations will center on projects and collaborations supported by the NIH. We’re looking forward to the opportunity to interact with you, as we all seek ways to advance our shared goals of finding more effective treatments and ultimately putting an end to Alzheimer’s disease and related dementias.
Finding NIH staff
NIA leadership and NIH staff are participating in several sessions and meetings, so keep any eye out for us if you want to touch base. If you’re interested in NIH projects and/or support, you may want to check out these sessions:
ISTAART Student Workshop Series: Federal Dementia Research: Priorities and Opportunities for Funding from the U.S. National Institutes of Health (NIH)
Sunday, July 16, 12:00 – 1:45 p.m.
The session is sponsored by the International Society to Advance Alzheimer’s Research and Treatment (ISTAART). Seating and lunch are available on a first-come, first-served basis; priority seating is reserved for ISTAART members.
NIA Director Dr. Richard Hodes and Dr. Roderick Corriveau, National Institute of Neurological Disorders and Stroke, will join me to describe federal priorities and funding opportunities in Alzheimer’s disease and related dementias research. The session will include time for one-on-one consults with NIA program staff and scientific review officers on research and career development grants.
Total MRI Burden of Cerebral Small Vessel Disease is Associated with Cognitive Decline and an Increased Risk of Dementia in Older People: The Ages-Reykjavik Study
Sunday, July 16, 4:45 – 5:00 p.m.
Dr. Jie Ding of NIA’s Laboratory of Epidemiology and Population Science will describe results of brain imaging in a cohort of older people in Iceland during a session addressing a life course approach to risk factors for Alzheimer’s and dementia.
Alliance of Women for Alzheimer’s Research PIA: Early Career Mentoring Breakfast
Monday, July 17, 7:00 – 8:15 a.m.
Dr Laurie Ryan, chief of the Dementias of Aging Branch, will participate in this event which provides an opportunity for students, post-doctoral fellows, and early stage investigators to meet with scientific leaders in Alzheimer's and dementia research and discuss topics related to careers and networking.
ISTAART Student Workshop Series: Careers in Science
Tuesday, July 18, 12:00 – 1:45 p.m.
The session is sponsored by ISTAART. Seating and lunch are available on a first-come, first-served basis; priority seating is reserved for ISTAART members.
Dr. Nina Silverberg, director of the Alzheimer’s Disease Centers Program, will participate in a workshop highlighting various career pathways open to dementia scientists, including academia, industry, government and the non-profit sector. Panelists will discuss their experiences and provide guidance in navigating the diverse career pathways. The target audience includes graduate students, postdoctoral fellows, and early career researchers.
Focused Topic Session: 2017 NIA–Alzheimer’s Association Research Framework to Investigate the Alzheimer’s Disease Continuum
Tuesday, July 18, 2:00 – 3:30 PM
Dr. Laurie Ryan will participate in a panel discussion of recent research data that support the need to develop a framework around the pathophysiologic changes throughout the Alzheimer’s disease continuum and the clinical context of symptoms for an individual.
Featured Research Session: Assessing the Effectiveness of Interventions to Prevent, Delay, or Slow Alzheimer’s Disease, Mild Cognitive Impairment, or Age-Related Cognitive Decline
Wednesday, July 19, 8:00 – 9:30 a.m.
NIA Director Dr. Richard Hodes will co-chair this session and Dr. Melinda Kelley, director of NIA’s Office of Legislation, Policy, and International Activities, will present. The session will focus on a recent rigorous approach to assessing science and establishing public messaging in these areas, with a discussion of the recent NIA-sponsored parallel studies by the Minnesota Evidence-based Practice Center (via the Agency for Healthcare Research and Quality) and the National Academies of Science, Engineering and Medicine.
Featured Research Session: Overview of Synapse Loss as the Final Common Path Towards Cognitive Impairment and Dementia.
Wednesday, July 19, 3:00 – 3:20 p.m.
I will participate in a session featuring updates on three major hypotheses on the underlying neurobiology of neurodegeneration: calcium, amyloid and inflammation. Presenters will discuss how potential links among these ideas could account for neurodegeneration.
Focused Topic Session: Advancing Health Disparities Research with the NIA
Thursday, July 20, 11:45 a.m. – 1:15 p.m.
Dr. Carl Hill, director of NIA’s Office of Special Populations, and Dr. Cerise Elliott, senior research program analyst in the NIA Division of Neuroscience, will serve as co-moderators of this session, which will highlight currently funded research on health disparities in Alzheimer’s disease. Eight presentations and accompanying discussions will provide important research highlights that bolster knowledge of the current studies working to address health disparities over the life course and in late life.
I hope you’ll take the time to stop and chat with NIH staff you see at the various presentations, plenary and poster sessions, and gatherings. It’s a great time to connect with colleagues, students, mentors, and everyone interested in Alzheimer’s research. See you in London!